Opportunity Information: Apply for EP IDS 13 001
Apply for EP IDS 13 001
- The Assistant Secretary for Preparedness and Response in the health sector is offering a public funding opportunity titled "Development of Sustainable Influenza Vaccine Production Capacity in Under Resourced Nations in Support of the Global Action Plan for Influenza Vaccines (GAP)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.360 Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development.
- This funding opportunity was created on Jun 4, 2013 and posted on Jun 4, 2013.
- Applicants must submit their applications by Jul 8, 2013 No Explanation. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $9,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $9,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts State governments Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) County governments For profit organizations other than small businesses Small businesses.
- Open to Non U.S. entities
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Development of Sustainable Influenza Vaccine Production Capacity in Under Resourced Nations in Support of the Global Action Plan for Influenza Vaccines (GAP)," was a discretionary funding program administered by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR), through BARDA (Biomedical Advanced Research and Development Authority). It was released under Funding Opportunity Number EP IDS 13 001 and aligned with CFDA 93.360, which covers BARDA's biodefense medical countermeasure development mission area. The central aim was to advance the World Health Organization's Global Action Plan for Influenza Vaccines (GAP) by strengthening influenza vaccine manufacturing capacity in under resourced, resource-poor nations. In practical terms, the opportunity was designed to help countries that have limited access to vaccine manufacturing build the infrastructure, technical capabilities, and operational stability needed to produce influenza vaccines in a reliable and sustainable way, while also reinforcing and complementing BARDA's existing International Influenza Vaccine Manufacturing Capacity Building Program.
The funding instrument was a cooperative agreement, which typically indicates that the U.S. government expected to have substantial involvement in the project beyond simply providing funds. This often means closer collaboration, technical input, progress monitoring, and coordinated planning between the awardee and the agency throughout the period of performance. The activity category was health, reflecting the public health and preparedness focus of the program, with an emphasis on pandemic readiness and improved global supply resilience for influenza vaccines.
Financially, the announcement indicated a single expected award, with an estimated total funding amount of $9,000,000. Notably, both the award ceiling and award floor were listed as $9,000,000, which strongly suggests the agency intended to make one award at that full amount rather than funding multiple smaller projects or offering a broad range of award sizes. There was no cost-sharing or matching requirement, meaning applicants were not required to contribute their own funds as a condition of receiving the award, which can be particularly important for applicants operating in resource-constrained environments.
Eligibility was broad across organizational types and included many common applicant categories such as state and local governments, tribal governments and tribal organizations, public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), and for-profit entities (including small businesses and other for-profit organizations). A key point in the eligibility information is that it was open to non-U.S. entities, signaling that the program was explicitly oriented toward international capacity building rather than domestic-only infrastructure development. This fits directly with the stated intent to strengthen vaccine production capacity in under resourced nations and to support global influenza preparedness objectives.
In terms of timing, the opportunity was posted and created on June 4, 2013, with an original and current closing date of July 8, 2013, and it was archived on August 7, 2013. Operationally, applicants who had trouble accessing the full announcement were directed to the Grants.gov Contact Center, with phone and email support provided. Overall, the program can be understood as a targeted, single-award investment intended to accelerate sustainable influenza vaccine manufacturing in settings where production capacity is limited, thereby supporting global readiness for seasonal influenza needs as well as future pandemic threats, in coordination with ongoing BARDA international manufacturing capacity-building efforts.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Development of Sustainable Influenza Vaccine Production Capacity in Under Resourced Nations in Support of the Global Action Plan for Influenza Vaccines (GAP)."
Which U.S. agency administered this funding opportunity?
This was a discretionary funding program administered by the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), through BARDA (Biomedical Advanced Research and Development Authority).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number listed for this opportunity is EP IDS 13 001.
What CFDA number is associated with this opportunity?
The opportunity aligned with CFDA 93.360, which covers BARDA's biodefense medical countermeasure development mission area.
What is the main purpose of the program?
The central aim was to advance the World Health Organization's Global Action Plan for Influenza Vaccines (GAP) by strengthening influenza vaccine manufacturing capacity in under resourced, resource-poor nations.
What kinds of outcomes was the opportunity designed to support?
Based on the description provided, it was designed to help build the infrastructure, technical capabilities, and operational stability needed for reliable and sustainable influenza vaccine production in countries with limited access to vaccine manufacturing, while improving global supply resilience for influenza vaccines.
How does this opportunity relate to the World Health Organization (WHO) GAP?
The program specifically aimed to support and advance the WHO Global Action Plan for Influenza Vaccines (GAP) by increasing sustainable influenza vaccine production capacity in under resourced nations.
How does this opportunity relate to BARDA's existing international programs?
It was intended to reinforce and complement BARDA's existing International Influenza Vaccine Manufacturing Capacity Building Program.
What type of funding instrument was used?
The funding instrument was a cooperative agreement.
What does it mean that the award was a cooperative agreement?
A cooperative agreement typically indicates the U.S. government expected to have substantial involvement beyond providing funds. As described, this can include closer collaboration, technical input, progress monitoring, and coordinated planning between the awardee and the agency during the period of performance.
What activity category did this opportunity fall under?
The activity category was health, reflecting a public health and preparedness focus with an emphasis on pandemic readiness and improved global influenza vaccine supply resilience.
How many awards were expected to be made?
The announcement indicated a single expected award.
What was the estimated total funding amount?
The estimated total funding amount was $9,000,000.
What were the award ceiling and floor?
Both the award ceiling and award floor were listed as $9,000,000.
What does it imply that the award ceiling and floor were both $9,000,000?
This strongly suggests the agency intended to make one award at the full amount, rather than funding multiple smaller projects or supporting a range of award sizes.
Was cost-sharing or matching required?
No. There was no cost-sharing or matching requirement stated for this opportunity.
Why might the lack of a cost-sharing requirement matter for applicants?
With no matching requirement, applicants were not required to contribute their own funds as a condition of receiving the award, which can be especially important for organizations working in resource-constrained settings.
Who was eligible to apply?
Eligibility was broad and included state and local governments, tribal governments and tribal organizations, public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), and for-profit entities (including small businesses and other for-profit organizations).
Were non-U.S. entities eligible to apply?
Yes. A key point in the eligibility information is that it was open to non-U.S. entities, aligning with the program's international capacity-building purpose.
What kinds of organizations does "for-profit entities" include under this opportunity?
The eligibility description explicitly included for-profit entities, including small businesses and other for-profit organizations.
When was the opportunity posted?
The opportunity was posted (and created) on June 4, 2013.
What was the application closing date?
The original and current closing date was July 8, 2013.
When was the opportunity archived?
The opportunity was archived on August 7, 2013.
What should applicants have done if they could not access the full announcement?
Applicants who had trouble accessing the full announcement were directed to contact the Grants.gov Contact Center using the phone and email support options provided in the announcement.
In plain terms, what problem was this grant trying to address?
It targeted limited influenza vaccine manufacturing capacity in under resourced nations by supporting the development of sustainable production capability, which can improve readiness for seasonal influenza needs and future pandemic threats.
Was this opportunity domestic-only, or international in focus?
It was international in focus, as reflected by the stated goal of building manufacturing capacity in under resourced nations and the explicit openness to non-U.S. entities.
What is the overall takeaway on the structure of this opportunity?
Based on the details provided, it was a targeted, single-award, cooperative agreement investment of $9,000,000 intended to accelerate sustainable influenza vaccine manufacturing capacity in resource-poor settings, coordinated with BARDA's related international capacity-building efforts.
Browse more opportunities from the same agency: Assistant Secretary for Preparedness and Response
Browse more opportunities from the same category: Health
Next opportunity: Services for Operational and Capacity Building Programs
Previous opportunity: Field Work at Chickasaw NRA NOI, Not a Request for Proposals
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for EP IDS 13 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (EP IDS 13 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Building Resilience Against Climate Effects (BRACE) Apply for CDC RFA EH13 1305 A Funding Number: CDC RFA EH13 1305 A Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| NINDS Research Education Opportunities (R25) Apply for PAR 13 240 Funding Number: PAR 13 240 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Unveiling the Genome Genetic Architecture of Severe Mental Disorders Revealed (Collaborative U01) Apply for PAR 13 241 Funding Number: PAR 13 241 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Resource Related Research Projects (R24) Apply for PAR 13 242 Funding Number: PAR 13 242 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Renewal of Centers of Biomedical Research Excellence COBRE(P20) Apply for PAR 13 243 Funding Number: PAR 13 243 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 13 001 Funding Number: CMS 1H0 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Grants to Support the Historically Black Colleges and Universities Health Services Research Grant Program Apply for CMS 1I0 13 001 Funding Number: CMS 1I0 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Consortium for Tobacco Use Cessation Technical Assistance Apply for CDC RFA DP13 1316 Funding Number: CDC RFA DP13 1316 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Rape Prevention and Education Program Apply for CDC RFA CE14 1401 Funding Number: CDC RFA CE14 1401 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,152,026 |
| Innovate for Health Apply for APS 641 13 000001 Funding Number: APS 641 13 000001 Agency: Ghana USAID Accra Category: Health Funding Amount: $3,500,000 |
| Fetal Alcohol Spectrum Disorders Apply for HRSA 13 261 Funding Number: HRSA 13 261 Agency: Health Resources and Services Administration Category: Health Funding Amount: $478,000 |
| FY13 Announcement of the Availability of Funds for Embryo Donation and/or Adoption Grant Projects Apply for PA EAA 13 001 Funding Number: PA EAA 13 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| CAPACITY DEVELOPMENT SUPPORT (CDS) Apply for SOL RFA 674 13 000005 Funding Number: SOL RFA 674 13 000005 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $220,000,000 |
| Service Area Competition Apply for HRSA 14 021 Funding Number: HRSA 14 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 14 022 Funding Number: HRSA 14 022 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 14 023 Funding Number: HRSA 14 023 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 14 024 Funding Number: HRSA 14 024 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 14 025 Funding Number: HRSA 14 025 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 14 026 Funding Number: HRSA 14 026 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 14 027 Funding Number: HRSA 14 027 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "EP IDS 13 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.